Wyeth Renal Cancer Drug Gets &#39;Fast Track&#39; Status
19633
Wyeth said on Tuesday that US regulators will review on an accelerated basis its experimental drug temsirolimus as a first line treatment for advanced renal cell carcinoma.
80541
NEW YORK, Jan 10  - Wyeth on Monday said it will  support changes in a nationwide legal settlement with users of  its "fen-phen" diet drugs, speeding up compensation to as many  as 40,000 people who say they were harmed by the recalled  medicines.
92266
Wyeth is seeking US approval in the next 18 months of seven new drugs that may ultimately generate more than $6 billion in annual revenue, chief executive Robert Essner told analysts.
400965
Medarex's partner advances one of its compounds into later stage clinical testing.
189561
US regulators said Tuesday they approved a new cancer drug from Genzyme Corp. for treating a type of childhood leukemia. The Food and Drug Administration, in a statement on its
692137
Amgen announces data from its top pipeline drug candidate.
537171
The kidney cancer pill Nexavar has shown promise in treating a small number of people with a type of blood cancer known as acute myeloid leukemia or AML, U.S. researchers said on Tuesday.
575085
NEW YORK/FRANKFURT  - A drug being developed by  Bayer AG and Onyx Pharmaceuticals Inc. shrank tumors in some  liver cancer patients and temporarily stabilized the disease in  others in a small clinical trial, the companies said on  Wednesday.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
717655
A kidney cancer drug became the first medicine to extend the life of patients with advanced liver cancer in a large study, adding about three months to survival compared with a placebo, according to a data released on Monday.
594161
Genzyme announces positive study results with a recently acquired drug.
697209
Drug maker Wyeth  is expected  to announce as early as today that it has received final  judicial approval of an amended settlement for diet drugs it no  longer sells, the Wall Street Journal reported on Wednesday.
51919
yetech Pharmaceuticals&#39; drug to treat the leading cause of blindness in the elderly appeared to move closer to a broad government approval yesterday after an advisory panel to the Food and Drug Administration spoke favorably about it.
734267
By Thomas Ginsberg, The Philadelphia Inquirer  Jan. 31--Here is something you may not hear every day: The drug giant Wyeth said yesterday that it was "surprised" to hear that it is about to face generic competition on its $216 million heart drug Inderal LA.
573459
A key study of its lead drug proceeds faster than expected.
88239
Scientists have developed a speedy way to monitor the effectiveness of cholesterol-reducing statin drugs.
351819
Drugmaker Wyeth WYE.N has reached a  tentative framework with a group of plaintiffs' lawyers to  settle nearly all remaining liability cases stemming from  allegations that some of its diet drugs damaged heart valves,  the Wall Street Journal reported on Tuesday, citing people  familiar with the negotiations.